Literature DB >> 11138622

Regulation of human neutrophil granule protein expression.

N Borregaard1, K Theilgaard-Mönch, O E Sørensen, J B Cowland.   

Abstract

The function of the mature polymorphonuclear neutrophil is dependent on its granules, each with its characteristic content of proteins. The granule proteins are formed at different stages during maturation of neutrophils from myeloblasts to segmented cells. The regulation of granule protein expression is controlled by a number of transcription factors, many of which are also essential for commitment of multipotent hematopoietic stem cells to lineage-committed myeloid progenitor cells and for differentiation of these progenitor cells; among these, PU.1 and C/EBPalpha stand out as critical for all granule proteins whereas AML-1 is critical for primary granule protein expression and C/EBPepsilon for secondary and tertiary granule protein expression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11138622     DOI: 10.1097/00062752-200101000-00005

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  22 in total

1.  Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells.

Authors:  Giorgia Santilli; Elena Almarza; Christian Brendel; Uimook Choi; Chiara Beilin; Michael P Blundell; Sneha Haria; Kathryn L Parsley; Christine Kinnon; Harry L Malech; Juan A Bueren; Manuel Grez; Adrian J Thrasher
Journal:  Mol Ther       Date:  2010-10-26       Impact factor: 11.454

2.  Herpes virus entry mediator synergizes with Toll-like receptor mediated neutrophil inflammatory responses.

Authors:  Philipp Haselmayer; Stefan Tenzer; Byoung S Kwon; Gundram Jung; Hansjörg Schild; Markus P Radsak
Journal:  Immunology       Date:  2006-11       Impact factor: 7.397

Review 3.  Strategies to generate functionally normal neutrophils to reduce infection and infection-related mortality in cancer chemotherapy.

Authors:  Hisham Abdel-Azim; Weili Sun; Lingtao Wu
Journal:  Pharmacol Ther       Date:  2019-08-27       Impact factor: 12.310

4.  Growth factor independence-1 (Gfi-1) plays a role in mediating specific granule deficiency (SGD) in a patient lacking a gene-inactivating mutation in the C/EBPepsilon gene.

Authors:  Arati Khanna-Gupta; Hong Sun; Theresa Zibello; Han Myung Lee; Richard Dahl; Laurence A Boxer; Nancy Berliner
Journal:  Blood       Date:  2007-01-23       Impact factor: 22.113

5.  Angels and demons: Th17 cells represent a beneficial response, while neutrophil IL-17 is associated with poor prognosis in squamous cervical cancer.

Authors:  Simone Punt; Gert Jan Fleuren; Eva Kritikou; Erik Lubberts; J Baptist Trimbos; Ekaterina S Jordanova; Arko Gorter
Journal:  Oncoimmunology       Date:  2015-02-03       Impact factor: 8.110

6.  Cytokine signals through STAT3 promote expression of granulocyte secondary granule proteins in 32D cells.

Authors:  Lei Wang; Murat O Arcasoy; Stephanie S Watowich; Bernard G Forget
Journal:  Exp Hematol       Date:  2005-03       Impact factor: 3.084

7.  Vitamin D(3) induces expression of human cathelicidin antimicrobial peptide 18 in newborns.

Authors:  Yuka Misawa; Atsushi Baba; Susumu Ito; Miyuki Tanaka; Masaaki Shiohara
Journal:  Int J Hematol       Date:  2009-11-28       Impact factor: 2.490

8.  Myelopoiesis dysregulation associated to sustained APRIL production in multiple myeloma-infiltrated bone marrow.

Authors:  T Matthes; T McKee; I Dunand-Sauthier; B Manfroi; S Park; J Passweg; B Huard
Journal:  Leukemia       Date:  2015-03-10       Impact factor: 11.528

9.  The lamin B receptor under transcriptional control of C/EBPepsilon is required for morphological but not functional maturation of neutrophils.

Authors:  Tatiana V Cohen; Kimberly D Klarmann; Krisada Sakchaisri; Jason P Cooper; Douglas Kuhns; Miriam Anver; Peter F Johnson; Simon C Williams; Jonathan R Keller; Colin L Stewart
Journal:  Hum Mol Genet       Date:  2008-07-11       Impact factor: 6.150

Review 10.  Neutrophil apoptosis and the resolution of infection.

Authors:  Adam D Kennedy; Frank R DeLeo
Journal:  Immunol Res       Date:  2009       Impact factor: 4.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.